General Archive
-
ArticlesLifeArc Translational Science Summit: Highlights and key takeaways
The first ever LifeArc Translational Science Summit was a resounding success! Held on 23 April in London, the event brought…
-
Articles6 challenges in rare disease research and how we can overcome them
Rare conditions, individually, have low patient numbers. However, with more than 7,000 rare diseases identified, collectively there are millions of…
-
ArticlesUnveiling the future of cell and gene therapies in the UK
In recent years, cell and gene therapies have been advancing at lightning speed, offering new hope to patients. However, there’s…
-
ArticlesNew Alzheimer’s treatment ‘lecanemab’ approved for use in the US
LifeArc played an instrumental role in the drug’s development through our antibody humanisation work.
-
ArticlesCatriona Crombie talks to Rare Revolution about LifeArc’s investment of more than £100 million into rare disease research by 2030
Catriona discusses why LifeArc is well placed to help overcome some of the obstacles in rare disease research
-
ArticlesHow LifeArc’s Neurodegeneration Translational Challenge is leading the charge against Motor Neurone Disease
June 21st is Global MND Awareness Day, a day to raise worldwide awareness of MND (Motor Neurone Disease) and to…
-
ArticlesMeet our industrial placement students – class of 2023
Find out what this year’s cohort of industrial placement students gained from the experience.
-
ArticlesInternational Women’s Day 2023
Tips on career advancement, from some of LifeArc’s incredible women
-
ArticlesHonouring the contribution of a remarkable trustee – Aisling Burnand CBE
Melanie Lee pays tribute to Aisling Burnand and her immense contribution to the life sciences sector.
-
ArticlesRare Disease Day 2023 – Robbie’s story
Robbie has a rare genetic neurodegenerative disease known as AP-4 Hereditary Spastic Paraplegia (AP-4 HSP) subtype SPG47.
-
ArticlesFour ways we support rare disease research
LifeArc provides a range of advice, funding and science to help scientists turn promising research into potential treatments.
-
ArticlesLifeArc awards £3 million to advance promising early rare disease research from the lab to the patient
Pump-prime funding to help researchers get innovative approaches off the ground